News

Nutriband Inc. Issued Full Patent from the Korean Intellectual Property Office for Its "Abuse and Misuse Deterrent Transdermal System" Application

Nutriband Inc. Announces $1 Million Share Repurchase Authorization

Nutriband Inc. initiates plans to offer Topical lotion contract manufacturing services

Nutriband Inc. Receives cGMP Certification for Manufacturing Subsidiary

Nutriband Inc. to Ring NASDAQ Stock Market Opening Bell on December 3, 2021

Nutriband Inc. Initiates Commercial Development of Lead Product AVERSA(TM) Fentanyl

Nutriband Inc. Interview to Air on Bloomberg U.S. on the RedChip Money Report®

Nutriband Inc. Signs Exclusive Manufacturing Agreement for Diocheck(TM) Visual COVID-19 Antibody Indicator Patch

Nutriband Inc.'s AVERSA(R) technology receives Notice of Allowance from United States Patent and Trademark Office (USPTO)

Get in touch

To find out more, or to enquire about our partnership options, please contact our team who can help find the right solution for your business.